What We’re Reading: Rising Flu Cases; RSV Drug Shortage; Forever Chemical Restrictions
Health officials said that at least 7 states reported high levels of illness, with cases also rising in other parts of the country; a group of Senate Democrats demanded answers about the shortage of nirsevimab, a new respiratory syncytial virus (RSV) drug; Pentagon officials told Congress that eliminating per- and polyfluorinated substances would undermine military readiness.
What We’re Reading: Updated Anthrax Guidelines; At-Home STI Test; Veteran Psychedelic Therapy
The CDC has published updated recommendations for the postexposure prevention and treatment of Bacillus anthracis (anthrax) infection; the FDA has granted marketing approval to an at-home chlamydia and gonorrhea test; lawmakers and Veterans Affairs officials acknowledge the potential for psychedelic drugs to treat veterans’ mental health conditions and prevent suicide.
What We’re Reading: UnitedHealth Lawsuit; Fentanyl Crackdown; Global Heat Deaths Increase
A class action lawsuit was filed against UnitedHealth Group and a subsidiary for allegedly using an algorithm to deny rehabilitation coverage for seriously ill patients; US and China officials are finalizing an agreement to crack down on fentanyl; a study published Tuesday projected global heat deaths to increase by 370% if no action is taken against global warming.
What We’re Reading: Weight Loss Drug Costs; Young Black Students With ADHD; AI in Health Care
A senator opposes the Biden drug price negotiation plan and proposes a new model to help manage weight loss drug costs; Black children are underdiagnosed with attention-deficit/hyperactivity disorder (ADHD) compared with their White peers; lawmakers and witnesses said that policy makers must balance innovation with potential harms when it comes to artificial intelligence (AI) in health care.
What We’re Reading: New HPV Screenings; Lung Cancer Pills; Migraine Relief Device
A study suggests that human papillomavirus (HPV) screenings should be updated due to effective HPV vaccines; a new study shows that osimertinib (Tagrisso, AstraZeneca) reduced both the 5-year risk of recurrent cancer and the risk of death in patients with stage 1B to 3A lung cancer; a new smartphone-controlled technology could help those who suffer from migraines.
What We’re Reading: Free HIV Medication; MA Anticompetitive Regulations; Surge in Syphilis Cases
Medicare may cover full cost of preexposure prophylaxis drugs; rules aim to prevent excessive compensation in Medicare Advantage (MA) market; health officials advocate for widespread syphilis testing and intervention.
What We’re Reading: AI Heart Attack Detection; FDA Menthol Ban; Shooting Survivor Care Obstacles
Artificial intelligence (AI) could help detect heart attack risk signs and prevent sudden cardiac death; Advocates demand the Biden administration finalize the proposed FDA ban on menthol cigarettes; Gun violence survivors and their families have many ongoing medical needs.
What We’re Reading: Pharmacy Staff Walkout; Male Parental Leave; FDA Reviewing SCD Therapy
Pharmacy workers embark on a multiday strike; Fathers are taking paid family leave to bond with their newborns; the FDA is set to evaluate a pioneering gene therapy for sickle cell disease (SCD).